Intraperitoneal (i.p.)administration of lipopolysaccharide (LPS), an outer cell wall component of gram-negative bacteria and Toll-like receptor 4 (TLR4) agonist, has long been known to trigger sickness behavior which includes anorexia and a decrease in locomotion, exploration and social interaction [1]. This evidence concerns the gene TLR4 and Anorexia.